AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER

Actavis Receives Approval from French Competition Authority for Pending Warner Chilcott Acquisition

 Uncategorized  Comments Off on Actavis Receives Approval from French Competition Authority for Pending Warner Chilcott Acquisition
Aug 102013
 

 

PARSIPPANY, N.J. and DUBLIN, IRELAND – August 9, 2013 – Actavis, Inc. (NYSE: ACT) and Warner Chilcott plc (NASDAQ: WCRX) today announced that they have received approval from the French Competition Authority for Actavis’ pending acquisition of Warner Chilcott. The companies previously received approval from the German Federal Cartel Office and have now received all ex-U.S. antitrust clearances required to complete the transaction.

read all at

http://www.pharmalive.com/french-authorities-approve-actavis-acquisition-of-warner-chilcott

………………………

………..

 

Bethlehem

 

Share
Jul 052013
 

Fibristal (ulipristal acetate)

Health Canada grants marketing approval for Actavis’ Fibristal to treat uterine fibroids
Health Canada has granted marketing approval for Actavis’ Fibristal (ulipristal acetate) to treat symptoms of uterine fibroids in adult women of reproductive age who are eligible for surgery…

 

http://regulatoryaffairs.pharmaceutical-business-review.com/news/health-canada-grants-marketing-approval-for-actavis-fibristal-to-treat-uterine-fibroids-260613

Share
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: